Skip to main content

Table 4 Adjusted hazard ratios for four-month survival among the population (n = 633)

From: Comparison of seven comorbidity scores on four-month survival of lung cancer patients

Comorbidity score

Median

[Interquartile range]

HR [95% CI]

P value

Type 3

P value

CCI

0.0 [0.0; 2.0]

  

0.1

0

 

1

  

1 or 2

 

1.1 [0.8; 1.4]

0.63

≥ 3

 

1.4 [1.0; 2.1]

0.04

ACCI*

3.0 [2.0; 4.0]

  

< 0.05

≤ 2

 

1

3

 

1.0 [0.8; 1.4]

0.88

 

4

 

1.3 [0.9; 1.7]

0.13

 

≥ 5

 

1.6 [1.1; 2.1]

< 0.01

 

CCI-lung

0.0 [0.0; 1.0]

  

0.08

0

 

1

1 ≤ CCI-lung ≤ 2

 

1.1 [0.9; 1.5]

0.31

≥ 3

 

1.5 [1.0; 2.2]

0.03

NCI*

0.0 [0.0; 1.7]

  

0.47

0 < NCI ≤ 1

 

1

1 < NCI ≤ 2

 

1.2 [0.9; 1.5]

0.30

2 < NCI < 3

 

1.1 [0.7; 1.7]

0.63

NCI ≥ 3

 

1.3 [0.9; 1.8]

0.16

NCI-lung

0.0 [0.0; 0.33]

  

0.22

< 0

 

1

0 = NCI ≤ 0.2

 

1.3 [0.7; 2.3]

0.50

0.2 < NCI ≤ 0.4

 

1.6 [0.8; 3.2]

0.14

NCI > 0.4

 

1.4 [0.8; 2.7]

0.26

Elixhauser

6.0 [2.0; 11.0]

  

< 0.01

Elixhauser ≤ 0 to Elixhauser ≤ 5

 

1

6 ≤ Elixhauser ≤ 11

 

1.4 [1.0; 1.8]

0.02

Elixhauser > 11

 

1.6 [1.2; 2.1]

< 0.01

Elixhauser-lung*

3.0 [0.0; 5.0]

  

< 0.01

≤ 0

 

1

1 ≤ Elixhauser-lung ≤ 3

 

1.2 [0.9; 1.7]

0.14

4 ≤ Elixhauser-lung ≤ 5

 

2.1 [1.5; 3.0]

< 0.01

Elixhauser-lung > 5

 

1.5 [1.1; 2.0]

0.02

  1. Adjusted for sex, presence of metastases, and histological type. Quantitative variables are expressed as medians [Interquartile range]; In bold: p < 0.05
  2. *sex is no longer significantly different in multivariate analysis with this score